Zurich Cantonal Bank’s iRadimed IRMD Stock Holding History

Zurich Cantonal Bank’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$533K	Buy	+5,532	New	+$553K	﹤0.01%	1799
2025 Q4	–	Sell	-5,557	Closed	-$477K	–	3023
2025 Q3	$395K	Buy	+5,557	New	+$370K	﹤0.01%	1867
2025 Q2	–	Sell	-7,815	Closed	-$410K	–	2597
2025 Q1	$410K	Sell	7,815 -787	-9%	-$44.2K	﹤0.01%	1717
2024 Q4	$473K	Buy	8,602 +3,632	+73%	+$191K	﹤0.01%	1663
2024 Q3	$250K	Buy	+4,970	New	+$229K	﹤0.01%	1992
2022 Q4	–	Sell	-3,085	Closed	-$93K	–	2877
2022 Q3	$93K	Sell	3,085 -11,768	-79%	-$410K	﹤0.01%	2283
2022 Q2	$504K	Buy	+14,853	New	+$532K	﹤0.01%	1223

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zurich Cantonal Bank's IRMD Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in iRadimed (IRMD) in Q1 2026: 5,532 shares worth $533K. The stake represents ﹤0.01% of the portfolio and ranks #1799 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in IRMD as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in IRMD in Q2 2022 and has held it in 7 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Zurich Cantonal Bank held 5,532 shares of iRadimed worth $533K as of Q1 2026.
iRadimed was a new Zurich Cantonal Bank position in Q1 2026.
iRadimed made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1799 holding.
Zurich Cantonal Bank first reported a position in iRadimed in Q2 2022 and has held it in 7 quarters since.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.